What To Expect | Pharmacy Conference Agenda | PDS Super Conference
It has been a challenging year for independent pharmacies. Now, more than ever, it is critical that you transform your pharmacy into a sustainable, profitable business.
Related Articles
An Overview of Vitamins and Supplements in Multiple Sclerosis
By examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.
As Biosimilar Substitutions Become More Common, Education and Patient Counseling Are Paramount
Pharmacists play an essential role in counseling patients on biosimilar substitution protocols and following state regulations regarding interchangeable medications.
Impact of Time to First Epinephrine Administration on Outcomes After In-Hospital Cardiac Arrest With Initial Nonshockable Rhythm
This study found no significant difference in the sustained return of spontaneous circulation or survival to hospital discharge based on the timing of the first…
Expert: Approval of Semaglutide Major Advancement for CKD, Cardiovascular Risk Reduction in Type 2 Diabetes
Semaglutide has been approved for reducing kidney disease progression and cardiovascular risk in patients with type 2 diabetes, marking a significant advancement in CKD management.
FDA Approves Interchangeable Biosimilar to Xolair
Omalizumab-igec is designed to attach to immunoglobulin E (IgE), which is produced at high levels among individuals with allergies.
Adults With High Ratio of Non-HDL Cholesterol to HDL Cholesterol Have Higher Sarcopenia Risk
Sarcopenia, a progressive skeletal order that involves the accelerated loss of muscle mass and function, is associated with adverse outcomes such as functional decline, frailty,…
Pharmacists Play a Crucial Role in Adalimumab Biosimilars for Patient Care
Adalimumab biosimilars differ from adalimumab in approved indications, concentration and dosage, and formulation.
OpCT-001, Stem Cell-Derived Therapy for Primary Photoreceptor Diseases, Receives FDA Fast Track Designation
With the new designation, OpCT-001 can receive expedited investigations into its potential to improve vision function in patients with primary photoreceptor diseases.
PBM Reform: Tackling Transparency, Pricing, and Patient Access
Policymakers and health care providers call for reforms to improve transparency, pricing, and patient access.
Presentation and Diagnosis of Primary Biliary Cholangitis
Panelists discuss how primary biliary cholangitis (PBC) often presents asymptomatically but can be diagnosed through elevated alkaline phosphatase levels, positive antimitochondrial antibodies, and liver biopsy…